Cologuard® is a noninvasive at-home colon cancer screening test for adults 45+ at average risk. See risk info and talk to your provider. Rx only.
Cologuard® is a noninvasive at-home colon cancer screening test for adults 45+ at average risk. See risk info and talk to your provider. Rx only.
Cologuard® is a noninvasive at-home colon cancer screening test for adults 45+ at average risk. See risk info and talk to your provider. Rx only.
Cologuard® is a noninvasive at-home colon cancer screening test for adults 45+ at average risk. See risk info and talk to your provider. Rx only.
In 2014, Exact Sciences launched Cologuard®,a noninvasive colon cancer screening option for adults 45 and older who are at average risk. Since launch, millions have used Cologuard® to screen for colon cancer at home. No special prep ...
$精密科学(EXAS)$ 假阳性较高,是Cologuard的不足之处。March 18th the New England Journal of Medicine published the full results of Exact Sciences (EXAS) colon cancer screening test Cologuard. The trial was in comparison to fecal immunochemical testing (FIT
The Food and Drug Administration on Monday approved the firstscreening test for colon cancer that uses patients' DNAto help spot potentially deadly tumors and growths. The Cologuard test from Exact Sciences detects irregular mutations in stool samples that can be an early warning sign of cancer. ...
Popular noninvasive colorectal cancer screening test, Cologuard, recently received permission from the FDA to expand its test. The FDA has expanded the approval of the noninvasive colorectal cancer (CRC) screening test Cologuard to include eligible at-risk individuals ≥45 years.1 The u...
The company recently shared positive results from its Blue-C study, intended to support an FDA approval bid for a second generation of its colon cancer screening test.
“As patient and physician demand for Cologuard continues to grow, momentum is increasing toward Cologuard becoming part of the standard of care in colon cancer screening,” said Kevin Conroy, chairman and CEO of Exact Science...